Articles from eSense Health Inc.
eSense Health Inc. is proud to announce the publication of a pivotal randomized clinical trial in the peer-reviewed journal Behaviour Research & Therapy, validating the efficacy of its flagship product, eSense—a digital program designed to support women experiencing Female Sexual Interest/Arousal Disorder (SIAD), a condition that affects up to 40% of women.
By eSense Health Inc. · Via Business Wire · April 3, 2025